Emerging Markets Regulatory Tracker: Australia, Brazil, India (Vol. 4 No. 23)
This article was originally published in PharmAsia News
Executive Summary
Australia’s TGA proposes new warning labels for pediatric OTC cough medicines and decongestants. Brazil requires 12-month notice before withdrawing products from the market and India’s CDSCO specifies format for fixed-dose combination drug submissions.
You may also be interested in...
Emerging Markets Regulatory Tracker: India Plans Regulatory Overhaul
India’s health ministry has laid out basic steps towards an overhaul of drug regulation at the local level, identifying a number of areas of concern.
Emerging Markets Regulatory Tracker: China Self-Audit Results Released
China has released the results of back on proposed standards for the accreditation of clinical trial committees, investigators and sites.
Emerging Markets Regulatory Tracker: China Device Classifications
China has finalized revised rules for the classification of medical devices, which will come into effect from the start of next year.